Skip to main content

Table 1 Clinical characteristics of patients

From: Integrated models of blood protein and metabolite enhance the diagnostic accuracy for Non-Small Cell Lung Cancer

 

NSCLC Group

HC Group

BPD Group

Total

110

100

108

Sex

 Male

68

60

57

 Female

42

40

51

Age, y

 Mean (SD)

61.4 (12.2)

59.5(14.2)

64.1(8.6)

 Range

27–82

24–81

25–89

TNM Stage

Type of BPD

 I

56(50.9%)

─

Tuberculosis 30 (27.8%)

 II

11(10.0%)

─

Lung nodules 18 (16.7%)

 III

17(15.5%)

─

Non-TB lung infection 40 (37.0%)

 IV

24(21.8%)

─

Others 20 (18.5%)

 Unknown

2(1.8%)

─

 

Histological type

 LUAD

88(80.0%)

─

 

 LUSC

20(18.2%)

─

 

 Other NSCLC

2 (1.8%)

─

 
  1. Abbreviations: SD Standard deviation, NSCLC Non-small cell lung cancer, HC Health control, BPD Benign pulmonary disease, LUAD Lung adenocarcinoma, LUSC Lung squamous cell carcinoma